Literature DB >> 7863014

On the significance of cholecystokinin receptors in panic disorder.

H J van Megen1, J A den Boer, H G Westenberg.   

Abstract

Interest in the biological aspects of panic disorder has been focussed mainly on the noradrenergic and serotonergic systems in the brain. Recently evidence has been found that Cholecystokinin (CCK) receptors in the Central Nervous System (CNS) may be involved in panic disorders. This hypothesis is based on the results of animal electrophysiological studies, animal models of anxiety and on challenge test using CCK fragments in humans. In this review, the studies evaluating the putative involvement of CCK, and especially CCK-B receptors, in panic disorder will be discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7863014     DOI: 10.1016/0278-5846(94)90090-6

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  2 in total

Review 1.  Clinical uses of gut peptides.

Authors:  J Geoghegan; T N Pappas
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

2.  The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.

Authors:  H J van Megen; H G Westenberg; J A den Boer; B Slaap; F van Es-Radhakishun; A C Pande
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.